Published in J Biol Chem on July 06, 2010
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. J Cell Biol (2011) 1.73
Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol (2013) 1.73
Many players in BCL-2 family affairs. Trends Biochem Sci (2014) 1.64
Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ (2011) 1.60
Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ (2013) 1.54
Direct activation of full-length proapoptotic BAK. Proc Natl Acad Sci U S A (2013) 1.53
BID-induced structural changes in BAK promote apoptosis. Nat Struct Mol Biol (2013) 1.45
Organization of the mitochondrial apoptotic BAK pore: oligomerization of the BAK homodimers. J Biol Chem (2013) 1.16
Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway. Br J Pharmacol (2014) 1.13
Assembly of the Bak apoptotic pore: a critical role for the Bak protein α6 helix in the multimerization of homodimers during apoptosis. J Biol Chem (2013) 1.12
Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function. Cell Death Differ (2014) 1.03
Where killers meet--permeabilization of the outer mitochondrial membrane during apoptosis. Cold Spring Harb Perspect Biol (2013) 1.03
Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species. Nat Commun (2015) 1.02
Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci U S A (2014) 0.99
Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax. Cell Death Dis (2015) 0.95
Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for Bak and Bax apoptotic function. PLoS One (2012) 0.95
Blockade of the BAK hydrophobic groove by inhibitory phosphorylation regulates commitment to apoptosis. PLoS One (2012) 0.95
BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis. Cell Rep (2013) 0.94
Dynamic interaction of cBid with detergents, liposomes and mitochondria. PLoS One (2012) 0.91
Mitochondria and apoptosis: emerging concepts. F1000Prime Rep (2015) 0.91
Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains. Cell Death Differ (2015) 0.89
Evaluation of the BH3-only protein Puma as a direct Bak activator. J Biol Chem (2013) 0.88
"Licensed to kill": tyrosine dephosphorylation and Bak activation. Cell Cycle (2011) 0.88
Beta-amyloid oligomers activate apoptotic BAK pore for cytochrome c release. Biophys J (2014) 0.87
Structural insights into membrane interaction and caveolar targeting of dynamin-like EHD2. Structure (2014) 0.86
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation. Cell (2016) 0.85
The functional differences between pro-survival and pro-apoptotic B cell lymphoma 2 (Bcl-2) proteins depend on structural differences in their Bcl-2 homology 3 (BH3) domains. J Biol Chem (2014) 0.84
Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives. PLoS One (2013) 0.82
Bak apoptotic function is not directly regulated by phosphorylation. Cell Death Dis (2013) 0.82
Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells. Genes Dev (2015) 0.80
The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane. FEBS J (2016) 0.78
Probing Structural Dynamics and Topology of the KCNE1 Membrane Protein in Lipid Bilayers via Site-Directed Spin Labeling and Electron Paramagnetic Resonance Spectroscopy. Biochemistry (2015) 0.77
Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis. BMC Complement Altern Med (2015) 0.77
In Situ Characterization of Bak Clusters Responsible for Cell Death Using Single Molecule Localization Microscopy. Sci Rep (2016) 0.77
Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore. Sci Rep (2016) 0.76
Doughnuts, daisy chains and crescent moons: the quest for the elusive apoptotic pore. EMBO J (2016) 0.76
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (2001) 23.42
Cell death: critical control points. Cell (2004) 22.56
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 13.87
Structure of lipid bilayers. Biochim Biophys Acta (2000) 11.31
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell (2001) 9.33
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell (2005) 8.73
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell (2002) 8.38
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev (2000) 8.35
The BCL-2 family reunion. Mol Cell (2010) 7.32
Structure of Bax: coregulation of dimer formation and intracellular localization. Cell (2000) 7.00
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell (1997) 5.95
Identifying conformational changes with site-directed spin labeling. Nat Struct Biol (2000) 5.76
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell (2008) 5.75
Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng (2001) 5.71
Motion of spin-labeled side chains in T4 lysozyme. Correlation with protein structure and dynamics. Biochemistry (1996) 5.52
Cytochrome C-mediated apoptosis. Annu Rev Biochem (2004) 5.38
VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science (2003) 4.92
Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell (2009) 4.37
Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ (2000) 4.34
A collision gradient method to determine the immersion depth of nitroxides in lipid bilayers: application to spin-labeled mutants of bacteriorhodopsin. Proc Natl Acad Sci U S A (1994) 4.27
Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci U S A (1995) 4.22
Transmembrane protein structure: spin labeling of bacteriorhodopsin mutants. Science (1990) 4.07
Recent advances in site-directed spin labeling of proteins. Curr Opin Struct Biol (1998) 3.94
A stapled BID BH3 helix directly binds and activates BAX. Mol Cell (2006) 3.86
Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol (2007) 3.86
A new spin on protein dynamics. Trends Biochem Sci (2002) 3.72
BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol (2000) 3.53
Crystal structures of spin labeled T4 lysozyme mutants: implications for the interpretation of EPR spectra in terms of structure. Biochemistry (2000) 3.46
Determination of the distance between two spin labels attached to a macromolecule. Proc Natl Acad Sci U S A (1995) 3.44
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J (2005) 3.11
Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science (2000) 3.06
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol Cell (2008) 2.97
Estimation of inter-residue distances in spin labeled proteins at physiological temperatures: experimental strategies and practical limitations. Biochemistry (2001) 2.89
Retracted Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol (2003) 2.83
Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol (2000) 2.74
Distance measurements in the nanometer range by pulse EPR. Chemphyschem (2002) 2.50
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell (2006) 2.24
How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol (2006) 2.14
Mitochondrial contact sites. Lipid composition and dynamics. J Biol Chem (1990) 2.10
Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. J Biol Chem (2004) 2.06
Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol Cell (2009) 2.04
Spin labeled cysteines as sensors for protein-lipid interaction and conformation in rhodopsin. Photochem Photobiol (1992) 1.96
Lipid bilayers: thermodynamics, structure, fluctuations, and interactions. Chem Phys Lipids (2004) 1.84
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ (2008) 1.80
Methods and applications of site-directed spin labeling EPR spectroscopy. Methods Cell Biol (2008) 1.72
Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J Cell Sci (2009) 1.70
Organization of diphtheria toxin T domain in bilayers: a site-directed spin labeling study. Science (1996) 1.64
VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep (2009) 1.62
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J (1999) 1.62
Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem (2009) 1.60
Structure of the KcsA potassium channel from Streptomyces lividans: a site-directed spin labeling study of the second transmembrane segment. Biochemistry (1999) 1.56
A multifrequency electron spin resonance study of T4 lysozyme dynamics. Biophys J (1999) 1.54
Motion of spin-labeled side chains in T4 lysozyme: effect of side chain structure. Biochemistry (1999) 1.51
Accessibility of nitroxide side chains: absolute Heisenberg exchange rates from power saturation EPR. Biophys J (2005) 1.44
A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis (2007) 1.38
Assembly of the mitochondrial apoptosis-induced channel, MAC. J Biol Chem (2009) 1.35
Bax forms an oligomer via separate, yet interdependent, surfaces. J Biol Chem (2010) 1.27
A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro. J Biol Chem (2006) 1.26
Spin labeling EPR. Photosynth Res (2009) 1.25
Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study. J Biol Chem (2004) 1.20
Site-directed spin labeling of proteins. Applications to diphtheria toxin. Methods Mol Biol (2000) 1.11
Simulation of nitroxide electron paramagnetic resonance spectra from brownian trajectories and molecular dynamics simulations. Biophys J (2008) 1.07
Conformational changes and protein stability of the pro-apoptotic protein Bax. J Bioenerg Biomembr (2009) 0.95
Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection. EMBO Rep (2007) 0.83
Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance. J Med Chem (2006) 1.75
Scanning probe acceleration microscopy (SPAM) in fluids: mapping mechanical properties of surfaces at the nanoscale. Proc Natl Acad Sci U S A (2006) 1.48
Properties of two cataract-associated mutations located in the NH2 terminus of connexin 46. Am J Physiol Cell Physiol (2013) 1.46
Molecular basis for activation of G protein-coupled receptor kinases. EMBO J (2010) 1.30
Structures of a Na+-coupled, substrate-bound MATE multidrug transporter. Proc Natl Acad Sci U S A (2013) 1.25
Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study. J Biol Chem (2004) 1.20
Asymmetric structure of the yeast F1 ATPase in the absence of bound nucleotides. J Biol Chem (2009) 1.20
Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci U S A (2012) 1.10
Structure of Mycobacterium smegmatis single-stranded DNA-binding protein and a comparative study involving homologus SSBs: biological implications of structural plasticity and variability in quaternary association. Acta Crystallogr D Biol Crystallogr (2005) 1.07
Structural insights into H+-coupled multidrug extrusion by a MATE transporter. Nat Struct Mol Biol (2013) 1.03
Ion selectivity of alpha-hemolysin with beta-cyclodextrin adapter. II. Multi-ion effects studied with grand canonical Monte Carlo/Brownian dynamics simulations. J Phys Chem B (2010) 1.02
Autoantibody-catalyzed hydrolysis of amyloid beta peptide. J Biol Chem (2007) 1.00
Identification of the substrate binding sites within the yeast mitochondrial citrate transport protein. J Biol Chem (2007) 0.99
Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. J Med Chem (2010) 0.98
Crystal structure of pyruvate dehydrogenase phosphatase 1 and its functional implications. J Mol Biol (2007) 0.97
Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis. Mol Cell Pharmacol (2010) 0.95
Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. Mol Pharmacol (2013) 0.94
Mycobacterium tuberculosis nucleoid-associated DNA-binding protein H-NS binds with high-affinity to the Holliday junction and inhibits strand exchange promoted by RecA protein. Nucleic Acids Res (2010) 0.93
An intersubunit salt bridge near the selectivity filter stabilizes the active state of Kir1.1. Biophys J (2009) 0.92
Ion selectivity of alpha-hemolysin with a beta-cyclodextrin adapter. I. Single ion potential of mean force and diffusion coefficient. J Phys Chem B (2010) 0.92
The yeast mitochondrial citrate transport protein: characterization of transmembrane domain III residue involvement in substrate translocation. J Biol Chem (2004) 0.91
Role of epidermal growth factor receptor signaling in RAS-driven melanoma. Mol Cell Biol (2005) 0.90
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. J Med Chem (2005) 0.90
Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor. Mol Pharmacol (2009) 0.88
External K activation of Kir1.1 depends on the pH gate. Biophys J (2007) 0.88
Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands. Org Biomol Chem (2014) 0.86
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands. Bioorg Med Chem Lett (2006) 0.85
A conserved arginine near the filter of Kir1.1 controls Rb/K selectivity. Channels (Austin) (2011) 0.85
A eukaryotic specific transmembrane segment is required for tetramerization in AMPA receptors. J Neurosci (2013) 0.84
Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity. J Biol Chem (2009) 0.83
Structural genomics of Caenorhabditis elegans: crystal structure of the tropomodulin C-terminal domain. Proteins (2004) 0.83
Structure of a monomeric variant of rhodopsin kinase at 2.5 Å resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.83
Sequence variability and geographic distribution of Lassa virus, Sierra Leone. Emerg Infect Dis (2015) 0.83
The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity. J Biol Chem (2010) 0.82
X-ray and molecular-dynamics studies on Mycobacterium leprae single-stranded DNA-binding protein and comparison with other eubacterial SSB structures. Acta Crystallogr D Biol Crystallogr (2010) 0.82
Microtubule +TIP protein EB1 binds to GTP and undergoes dissociation from dimer to monomer on binding GTP. Biochemistry (2014) 0.81
Crystal structures of mutant forms of the yeast F1 ATPase reveal two modes of uncoupling. J Biol Chem (2010) 0.81
Structure of sperm-specific protein SSP-19 from Caenorhabditis elegans. Acta Crystallogr D Biol Crystallogr (2004) 0.81
Characterization of the mitochondrial ATP synthase from yeast Saccharomyces cerevisae. J Bioenerg Biomembr (2011) 0.80
Binding of glutamate to the umami receptor. Biophys Chem (2010) 0.80
Introduction of the chloroplast redox regulatory region in the yeast ATP synthase impairs cytochrome c oxidase. J Biol Chem (2008) 0.80
The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio). Curr Eye Res (2007) 0.79
Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy. Bioorg Med Chem Lett (2002) 0.79
The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues. Biochim Biophys Acta (2006) 0.79
3-methyladenine-DNA glycosylase II: the crystal structure of an AlkA-hypoxanthine complex suggests the possibility of product inhibition. Bioconjug Chem (2002) 0.78
DNA binding, coprotease, and strand exchange activities of mycobacterial RecA proteins: implications for functional diversity among RecA nucleoprotein filaments. Biochemistry (2010) 0.78
Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. Bioorg Med Chem Lett (2009) 0.78
Mycobacterium leprae RecA is structurally analogous but functionally distinct from Mycobacterium tuberculosis RecA protein. Biochim Biophys Acta (2011) 0.78
Molecular dynamics study of a polymeric reverse osmosis membrane. J Phys Chem B (2009) 0.78
Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach. J Bioenerg Biomembr (2010) 0.77
Artificial spores: cytoprotective nanoencapsulation of living cells. Trends Biotechnol (2013) 0.77
Purification, nanocrystallization and preliminary X-ray analysis of a C-terminal part of tropomodulin protein 1, isoform A, from Caenorhabditis elegans. Acta Crystallogr D Biol Crystallogr (2003) 0.77
Moving the pH gate of the Kir1.1 inward rectifier channel. Channels (Austin) (2009) 0.77
The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate. J Bioenerg Biomembr (2008) 0.76
USA300 methicillin-resistant Staphylococcus aureus emerging as a cause of bloodstream infections at military medical centers. Infect Control Hosp Epidemiol (2013) 0.76
Neurons on nanotopographies: behavioral responses and biological implications. J Nanosci Nanotechnol (2014) 0.75
Reactions of in situ generated hydrated organotin cations with chelating O,O- or O,N-ligands: a possible structure-directing influence of the organic substituent on tin. Dalton Trans (2010) 0.75
2-Chloro-2'-deoxyadenosine: alteration of DNA:TATA element binding protein (TBP) interactions. J Mol Model (2003) 0.75
321: ADMISSION LEVELS OF HDL AND APOA1 CAN PREDICT THE NEUROLOGIC OUTCOME IN PATIENTS WITH OHCA. Crit Care Med (2016) 0.75
Cytoskeletal actin dynamics are involved in pitch-dependent neurite outgrowth on bead monolayers. Angew Chem Int Ed Engl (2014) 0.75
A degradable polydopamine coating based on disulfide-exchange reaction. Nanoscale (2015) 0.75
Pulmonary functions in plastic factory workers: a preliminary study. Indian J Physiol Pharmacol (2012) 0.75
Multivariate analyses for monitoring EDCs and PPCPs in a lake water. Water Environ Res (2014) 0.75
Expression, purification, crystallization of fragments from the C-terminal region of DFF45/ICAD. Acta Crystallogr D Biol Crystallogr (2003) 0.75
Corrigendum: Unlocking the genetic diversity of Creole wheats. Sci Rep (2016) 0.75
Metaplastic carcinoma of the breast: cytological diagnosis and diagnostic pitfalls. Acta Cytol (2011) 0.75
Organostannoxane-supported multiferrocenyl assemblies: synthesis, novel supramolecular structures, and electrochemistry. Chemistry (2005) 0.75
Filarial pleural effusion. Trop Doct (2007) 0.75
Lactococcus lactis BFE920 activates the innate immune system of olive flounder (Paralichthys olivaceus), resulting in protection against Streptococcus iniae infection and enhancing feed efficiency and weight gain in large-scale field studies. Fish Shellfish Immunol (2013) 0.75
Presence of the anti-leukemic nucleotide analog, 2-chloro-2'-deoxyadenosine-5'-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP). Arch Biochem Biophys (2007) 0.75